Community Research and Development Information Service - CORDIS

Abstract

The authors report investigations in human lymphomas. The levels of the following enzymes were determined: terminal deoxynucleotidyl transferase (Tdt), deoxyribonucleic acid polymers alpha (DP alpha), adenosine deaminase (ADA), purine nucleoside phosphorylase (PNP), thymidine and uridine kinases (TK and UK, respectively), and thymidine phosphorylase (ThPh). Moreover, cytochemical investigations were done in the group of Burkitt's lymphoma (BL) and lymphoblastic lymphoma (LL), and ultrastructural studies were performed in seven of the nine LL of this series. These results were obtained: (1) TdT (90 cases) was highly specific for LL; eight of nine LL were positive, non-convoluted LL was probably related to TdT normal medullary thymocytes, and had an unfavourable clinical course with resistance to a vincristine and prednisone including treatment (2) ADA (61 cases) could distinguish clearly between the high levels of LL and the low levels found in any other group of lymphomas; among LL, the highest values were found in T- cell derived neoplasias, and the lowest value in a periodic acid-Schiff (AS) positive, acid phosphatase negative case that showed the presence of large nucleoli at the ultrastructural analysis, a finding that is unusual for LL and possibly related to a more immature differentiation stage; (3) PNP (39 cases) values alone were not clinically relevant, but together with ADA levels, a subset of T-LL with high ADA:PNP ratio could be selected among LL; (4) DP alpha (61 cases), and TK and UK (37 cases) were found in concentrations reflecting the malignancy of the non-Hodgkin's lymphoma, and were more elevated in the high grade malignant lymphomas; (5) ThPh (34 cases) was always elevated in Hodgkin's disease, but low in Burkitt's lymphoma and LL; thus, they had a high TK:ThPh ratio that could be useful in predicting clinical response to thymidine treatment. The authors think that taken together, multiple enzyme determinations could be useful in the characterization of human lymphomas.

Additional information

Authors: VEZZONI P, UNIVERSITA DI MILANO (ITALY);ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI, MILANO (ITALY);JRC ISPRA ISPRA ESTAB. (ITALY) (I),;LUCCHINI R, UNIVERSITA DI MILANO (ITALY);ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI, MILANO (ITALY);JRC ISPRA ISPRA ESTAB. (ITALY) (I),;VEZZONI M A, UNIVERSITA DI MILANO (ITALY);ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI, MILANO (ITALY);JRC ISPRA ISPRA ESTAB. (ITALY) (I),;GIARDINI R, UNIVERSITA DI MILANO (ITALY);ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI, MILANO (ITALY);JRC ISPRA ISPRA ESTAB. (ITALY) (I),;LOMBARDI L, UNIVERSITA DI MILANO (ITALY);ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI, MILANO (ITALY);JRC ISPRA ISPRA ESTAB. (ITALY) (I),;RILKE F, UNIVERSITA DI MILANO (ITALY);ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI, MILANO (ITALY);JRC ISPRA ISPRA ESTAB. (ITALY) (I),;CLERICI L UNIVERSITA DI MILANO (ITALY), UNIVERSITA DI MILANO (ITALY);ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI, MILANO (ITALY);JRC ISPRA ISPRA ESTAB. (ITALY) (I),;ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI, MILANO (ITALY), UNIVERSITA DI MILANO (ITALY);ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI, MILANO (ITALY);JRC ISPRA ISPRA ESTAB. (ITALY) (I),;JRC ISPRA ISPRA ESTAB. (ITALY) (I),, UNIVERSITA DI MILANO (ITALY);ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI, MILANO (ITALY);JRC ISPRA ISPRA ESTAB. (ITALY) (I),
Bibliographic Reference: CANCER, VOL. 54 (1984), NO. 3, PP. 489-499
Record Number: 1989123103900 / Last updated on: 1987-01-01
Category: PUBLICATION
Available languages: en